The Creatinine Measurement Market size is projected to reach US$ 982.51 million by 2031 from US$ 514.49 million in 2023. The market is expected to register a CAGR of 8.4% in 2023–2031. Point-of-care renal functioning testing will likely remain a key creatinine measurement market trend.
The aging population is vastly vulnerable to chronic kidney conditions. For instance, according to the research conducted by the American Diabetes Association in 2021, an estimated 38.4 million Americans, or 11.6% of the population, are suffering from diabetes. The percentage of Americans aged 65 and older remains high at approximately 30%. Diabetes in adults generates a higher risk of kidney failure. For instance, according to a study published by the National Kidney Foundation, an estimated 30.0% of diabetic patients suffer from kidney disease each year globally. Thus, the increasing geriatric population is expected to boost the creatinine measurement market growth over the forecast period.
Creatinine measurement is an analysis method used to assess kidney function and diagnose kidney diseases. An elevated creatinine level in urine indicates kidney damage or diseases such as chronic kidney diseases or acute kidney injury. The market's growth is accredited to key driving factors such as the increasing incidence of chronic kidney diseases and the increasing geriatric population. However, the shift towards adopting new biomarkers is supposed to restrain the market's growth during the forecast years.
As per the National Kidney Foundation, the worldwide occurrence of chronic kidney disease (CKD) is increasing. About 10% of the global population is adopted by CKD, and millions die each year because they do not have an approach to reasonable treatment. Over 2 million affected individuals receive treatment through dialysis or a kidney transplant. The majority are treated in only five developed countries—the US, Japan, Germany, Brazil, and Italy. These five developed countries serve only 12% of the world's population. According to the 2019 Global Burden of Disease study, chronic kidney diseases account for 15% of worldwide mortality.
Due to the growing dominance of chronic kidney diseases among the masses, it is widely recognized as a global health issue. According to the American Society of Nephrology (ASN), there are ongoing recent advances in molecular diagnostics that are making ways to manage patients who are suffering from kidney-related disorders. Therefore, increasing chronic kidney disorders coupled with the benefits of creatinine measurement to recognize the condition of kidneys will likely boost the demand for creatinine measurement devices during the forecast period..
The growing healthcare industry in developing economies of Asia Pacific builds better prospects for market players to expand their business. The huge patient base in these countries is generating demand for advanced diagnostic systems. For instance, according to the global burden of disease data, India has 18% of the world’s population; however, the country holds about 17% of the global burden of kidney diseases. Additionally, an increasing number of dialysis procedures represent the massive growth in the prevalence of renal diseases. Furthermore, according to estimates published by the Global Burden of Disease, China alone has 119.5 million renal disease patients. Thus, the rapidly growing incidence of kidney diseases coupled with the demand-supply gap in diagnostic tests is predicted to offer lucrative opportunities for growth of the market by 2031.
Key segments that contributed to the derivation of the creatinine measurement market analysis are contaminants, technology, and food type.
The geographic scope of the creatinine measurement market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
The creatinine measurement market in North America is significantly In North America, the creatinine measurement market is currently in the growth phase and experiencing exponential growth. Increasing geriatric population associated with the various kidney diseases, favorable reimbursement policies for dialysis, increasing healthcare expenditure, increasing growing number of hospitals and clinics offering creatinine measurement services, advancements in the technological developments, and the major presence of the key players in this market are among the factors is going to propelling the market growth.
In addition, favorable reimbursement scenario in the US is also driving the growth of the market by increasing the adoption of the urinary catheters during various surgical procedures. Several insurance companies provide reimbursement for laboratory services. Medicare provides reimbursements using either the Physician Fee Schedule (PFS) or the Clinical Laboratory Fee Schedule (CLFS), depending on the service. In addition, laboratories also provide services to beneficiaries of other government programs such as Medicaid, TRICARE and the Federal Employee Health Benefit Plan (FEHBP), as well as commercial plans.
The regional trends and factors influencing the Creatinine Measurement Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Creatinine Measurement Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 514.49 Million |
| Market Size by 2031 | US$ 982.51 Million |
| Global CAGR (2023 - 2031) | 8.4% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Creatinine Measurement Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Creatinine Measurement Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The creatinine measurement market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:
The “Creatinine Measurement Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas: